Literature DB >> 25441291

Thymic stromal lymphopoietin signaling in CD4(+) T cells is required for TH2 memory.

Qun Wang1, Jianguang Du1, Jingjing Zhu1, Xiaowei Yang2, Baohua Zhou3.   

Abstract

BACKGROUND: Thymic stromal lymphopoietin (TSLP) is a key factor in the development of allergic asthma. Numbers of TH2 memory cells gradually increase in allergic patients with the progression of disease and persist in the lungs during remission, although the mechanism is not clear.
OBJECTIVE: We sought to define the role of TSLP in TH2 memory cell generation and maintenance in vivo.
METHODS: Adoptive transfer of wild-type and thymic stromal lymphopoietin receptor (TSLPR)-deficient ovalbumin-specific CD4(+) T cells before TH2 sensitization was used to define T cell-specific TSLP effects. Atopic dermatitis and increased serum TSLP concentrations were induced by topical application of the vitamin D3 analog MC903. Memory cells in peripheral blood were monitored weekly with flow cytometry. Memory recall was tested after intranasal ovalbumin challenge.
RESULTS: TSLP signaling in CD4(+) T cells is required for the generation/maintenance of memory cells after in vivo priming. TSLPR-deficient CD4(+) T cells have no defects in proliferation but do not survive 1 week after sensitization, and increased TSLP expression during sensitization significantly increased the frequency of memory cells. Although in vitro-differentiated TSLPR-deficient TH2 cells develop into memory cells with equal efficiency to wild-type cells, the recall response to airway antigen challenge is impaired. Moreover, after antigen challenge of mice with established TH2 memory, TSLP signaling in CD4(+) T cells significantly affects memory cell generation/maintenance from secondary effector cells.
CONCLUSION: TSLP signaling in CD4(+) T cells is required for not only TH2 memory cell formation in vivo but also the recall response of the memory cells to local antigen challenge.
Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  T(H)2 memory; Thymic stromal lymphopoietin; allergic airway inflammation; eosinophilia; memory recall

Mesh:

Substances:

Year:  2014        PMID: 25441291      PMCID: PMC4355221          DOI: 10.1016/j.jaci.2014.09.015

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  49 in total

Review 1.  Targeting memory Th2 cells for the treatment of allergic asthma.

Authors:  Michelle M Epstein
Journal:  Pharmacol Ther       Date:  2005-08-02       Impact factor: 12.310

2.  Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice.

Authors:  Baohua Zhou; Michael R Comeau; Thibaut De Smedt; H Denny Liggitt; Martin E Dahl; David B Lewis; Dora Gyarmati; Theingi Aye; Daniel J Campbell; Steven F Ziegler
Journal:  Nat Immunol       Date:  2005-09-04       Impact factor: 25.606

Review 3.  Regulation of CD4 T cell memory by OX40 (CD134).

Authors:  Shahram Salek-Ardakani; Michael Croft
Journal:  Vaccine       Date:  2005-09-07       Impact factor: 3.641

4.  Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis.

Authors:  Mei Li; Pierre Hener; Zhikun Zhang; Shigeaki Kato; Daniel Metzger; Pierre Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-31       Impact factor: 11.205

Review 5.  Control of CD4+ T-cell memory by cytokines and costimulators.

Authors:  Hans Dooms; Abul K Abbas
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

6.  Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells.

Authors:  Yui-Hsi Wang; Tomoki Ito; Yi-Hong Wang; Bernhard Homey; Norihiko Watanabe; Rachel Martin; Christopher J Barnes; Bradley W McIntyre; Michel Gilliet; Rakesh Kumar; Zhengbin Yao; Yong-Jun Liu
Journal:  Immunity       Date:  2006-06       Impact factor: 31.745

7.  Induction of IL-4 expression in CD4(+) T cells by thymic stromal lymphopoietin.

Authors:  Miyuki Omori; Steven Ziegler
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

8.  Asthma severity is associated with an increase in both blood CXCR3+ and CCR4+ T cells.

Authors:  Kazuyoshi Kurashima; Masaki Fujimura; Shigeharu Myou; Yoshihisa Ishiura; Nobuyuki Onai; Kouji Matsushima
Journal:  Respirology       Date:  2006-03       Impact factor: 6.424

9.  Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin.

Authors:  Jane Yoo; Miyuki Omori; Dora Gyarmati; Baohua Zhou; Theingi Aye; Avery Brewer; Michael R Comeau; Daniel J Campbell; Steven F Ziegler
Journal:  J Exp Med       Date:  2005-08-15       Impact factor: 14.307

10.  Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells.

Authors:  Mirjam Kool; Thomas Soullié; Menno van Nimwegen; Monique A M Willart; Femke Muskens; Steffen Jung; Henk C Hoogsteden; Hamida Hammad; Bart N Lambrecht
Journal:  J Exp Med       Date:  2008-03-24       Impact factor: 14.307

View more
  28 in total

1.  Inhibition of JAK/STAT pathway restrains TSLP-activated dendritic cells mediated inflammatory T helper type 2 cell response in allergic rhinitis.

Authors:  Zhaohui Shi; Weihong Jiang; Min Wang; Xiaocheng Wang; Xiaoyuan Li; Xiaodong Chen; Li Qiao
Journal:  Mol Cell Biochem       Date:  2017-02-18       Impact factor: 3.396

2.  Transplantation of human skin microbiota in models of atopic dermatitis.

Authors:  Ian A Myles; Kelli W Williams; Jensen D Reckhow; Momodou L Jammeh; Nathan B Pincus; Inka Sastalla; Danial Saleem; Kelly D Stone; Sandip K Datta
Journal:  JCI Insight       Date:  2016-07-07

Review 3.  Immunity to gastrointestinal nematode infections.

Authors:  D Sorobetea; M Svensson-Frej; R Grencis
Journal:  Mucosal Immunol       Date:  2018-01-03       Impact factor: 7.313

4.  TSLP signaling in CD4+ T cells programs a pathogenic T helper 2 cell state.

Authors:  Yrina Rochman; Krista Dienger-Stambaugh; Phoebe K Richgels; Ian P Lewkowich; Andrey V Kartashov; Artem Barski; Gurjit K Khurana Hershey; Warren J Leonard; Harinder Singh
Journal:  Sci Signal       Date:  2018-03-13       Impact factor: 8.192

Review 5.  IL-9-producing cells in the development of IgE-mediated food allergy.

Authors:  Dana Shik; Sunil Tomar; Jee-Boong Lee; Chun-Yu Chen; Andrew Smith; Yui-Hsi Wang
Journal:  Semin Immunopathol       Date:  2016-12-01       Impact factor: 9.623

6.  IL-4 impairs wound healing potential in the skin by repressing fibronectin expression.

Authors:  Ana P M Serezani; Gunseli Bozdogan; Sarita Sehra; Daniel Walsh; Purna Krishnamurthy; Elizabeth A Sierra Potchanant; Grzegorz Nalepa; Shreevrat Goenka; Matthew J Turner; Dan F Spandau; Mark H Kaplan
Journal:  J Allergy Clin Immunol       Date:  2016-08-20       Impact factor: 10.793

Review 7.  Probing the Skin-Brain Axis: New Vistas Using Mouse Models.

Authors:  Aliće Weiglein; Evelyn Gaffal; Anne Albrecht
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

8.  IL-25 and CD4(+) TH2 cells enhance type 2 innate lymphoid cell-derived IL-13 production, which promotes IgE-mediated experimental food allergy.

Authors:  Jee-Boong Lee; Chun-Yu Chen; Bo Liu; Luke Mugge; Pornpimon Angkasekwinai; Valeria Facchinetti; Chen Dong; Yong-Jun Liu; Marc E Rothenberg; Simon P Hogan; Fred D Finkelman; Yui-Hsi Wang
Journal:  J Allergy Clin Immunol       Date:  2015-11-10       Impact factor: 10.793

9.  IL33 contributes to diesel pollution-mediated increase in experimental asthma severity.

Authors:  Eric B Brandt; Paige E Bolcas; Brandy P Ruff; Gurjit K Khurana Hershey
Journal:  Allergy       Date:  2020-01-31       Impact factor: 13.146

10.  A tissue checkpoint regulates type 2 immunity.

Authors:  Steven J Van Dyken; Jesse C Nussbaum; Jinwoo Lee; Ari B Molofsky; Hong-Erh Liang; Joshua L Pollack; Rachel E Gate; Genevieve E Haliburton; Chun J Ye; Alexander Marson; David J Erle; Richard M Locksley
Journal:  Nat Immunol       Date:  2016-10-17       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.